Suppr超能文献

鼠源和人源单克隆抗体可预防多种基因型日本脑炎病毒感染。

Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus.

机构信息

Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

出版信息

mBio. 2018 Feb 27;9(1):e00008-18. doi: 10.1128/mBio.00008-18.

Abstract

Japanese encephalitis virus (JEV) remains a leading cause of viral encephalitis worldwide. Although JEV-specific antibodies have been described, an assessment of their ability to neutralize multiple genotypes of JEV has been limited. Here, we describe the development of a panel of mouse and human neutralizing monoclonal antibodies (MAbs) that inhibit infection in cell culture of four different JEV genotypes tested. Mechanism-of-action studies showed that many of these MAbs inhibited infection at a postattachment step, including blockade of virus fusion. Mapping studies using site-directed mutagenesis and hydrogen-deuterium exchange with mass spectrometry revealed that the lateral ridge on domain III of the envelope protein was a primary recognition epitope for our panel of strongly neutralizing MAbs. Therapeutic studies in mice demonstrated protection against lethality caused by genotype I and III strains when MAbs were administered as a single dose even 5 days after infection. This information may inform the development of vaccines and therapeutic antibodies as emerging strains and genotypic shifts become more prevalent. Although Japanese encephalitis virus (JEV) is a vaccine-preventable cause of viral encephalitis, the inactivated and live attenuated platforms available are derived from strains belonging to a single genotype (GIII) due to its historical prevalence in areas of JEV epidemics. Related to this, studies with vaccines and antibodies have focused on assessing the and protective responses to homologous or heterologous GIII strains. An epidemiological shift in JEV genotype distribution warrants the induction of broadly neutralizing antibody responses that inhibit infection of multiple JEV genotypes. Here, we generated a panel of mouse and human neutralizing monoclonal antibodies and evaluated their inhibitory activity, epitope location, and capacity for protection against multiple JEV genotypes in mice.

摘要

日本脑炎病毒(JEV)仍然是全球病毒性脑炎的主要原因。虽然已经描述了 JEV 特异性抗体,但对其中和多种 JEV 基因型的能力的评估受到限制。在这里,我们描述了一组小鼠和人源中和单克隆抗体(MAb)的开发,这些抗体可抑制在四种不同 JEV 基因型的细胞培养中感染。作用机制研究表明,这些 MAb 中的许多在附着后步骤中抑制感染,包括阻止病毒融合。使用定点突变和氢氘交换与质谱联用的作图研究表明,包膜蛋白 III 结构域上的侧脊是我们的一组强中和 MAb 的主要识别表位。在小鼠中的治疗研究表明,当 MAb 在感染后 5 天甚至单剂量给药时,可预防 I 型和 III 型菌株引起的致死性。这些信息可能会为新兴菌株和基因型转变变得更为普遍时疫苗和治疗性抗体的开发提供信息。尽管日本脑炎病毒(JEV)是一种可通过疫苗预防的病毒性脑炎病原体,但由于其在 JEV 流行地区的历史流行,现有的灭活和减毒活疫苗平台均源自单一基因型(GIII)的菌株。与此相关的是,疫苗和抗体的研究主要集中在评估对同源或异源 GIII 菌株的保护作用和保护性反应上。JEV 基因型分布的流行病学转变需要诱导广泛中和抗体反应,以抑制多种 JEV 基因型的感染。在这里,我们生成了一组小鼠和人源中和单克隆抗体,并评估了它们在抑制多种 JEV 基因型中的抑制活性、表位位置和保护能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32a8/5829823/4959f94e590e/mbo0011837440001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验